Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Binzhou Zhiyuan Biotechnology is a leading high-tech enterprise based in China that specializes in the research, development, and production of cyclodextrins and their derivatives. The company is a major supplier of pharmaceutical excipients, notably Hydroxypropyl Betadex and Sulfobutyl Ether Beta Cyclodextrin Sodium, which are used to enhance the solubility, stability, and bioavailability of active pharmaceutical ingredients. Operating under strict GMP conditions, the company holds multiple Drug Master File (DMF) registrations with the US FDA and China's NMPA. Their products serve a global market across the pharmaceutical, cosmetic, food, and environmental protection industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Binzhou Zhiyuan Biotechnology.